Opportunity

SAM #ARPA-H-SN-26-164

ARPA-H SURPASS program seeks teams to develop and validate adaptive clinical-trial platforms

Buyer

ARPA-H

Posted

September 30, 2026

Respond By

October 13, 2026

Identifier

ARPA-H-SOL-26-164

NAICS

541714, 541715, 325414

ARPA-H’s Proactive Health Office is seeking teams to develop and clinically validate SURPASS adaptive platform trials for a single disease area. - Government buyer: Advanced Research Projects Agency for Health (ARPA-H), within the National Institutes of Health (NIH), Department of Health and Human Services (HHS); sub-agency: Proactive Health Office (PHO). - Program: Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS), solicitation ARPA-H-SOL-26-164. Multiple awards are anticipated. - Requested work: One integrated Core Platform Team will develop and validate a persistent adaptive platform trial for one disease area, combining a phaseless design and simulation engine, continuous inference and adaptation-validity capabilities, and AI-enabled clinical operations. - Team and trial requirements: Propose at least three drug or biologic intervention arms, including at least two unapproved interventions and one with no prior human data; include at least two for-profit sponsors, including a startup or small company; and build a network of at least six clinical sites. The first site must open to enrollment by program Year 2. - Performance: Five years total, comprising a 24-month platform and capability buildout stage and a 36-month validation and deployment stage. The platform is intended to remain economically sustainable for approximately 10 years after program funding ends. - Products and manufacturers: No specific products, part numbers, quantities of equipment, OEMs, or commercial vendors are identified. The requested effort is an integrated research and clinical-trial platform service. - Award structure: ARPA-H anticipates multiple awards. The notice also describes an informational webinar and Proposers’ Day.

Description

The Advanced Research Projects Agency for Health (ARPA-H) posts this Special Notice in support of its Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) Program.

Interested parties are invited to review the attached Notice related to an informational webinar on 15 OCT 2026 and a 2-day Proposers’ Day on 6 and 9 NOV 2026 in support of SURPASS.  

For more information related to the SURPASS opportunity, see solicitation ARPA-H-SOL-26-164.

All questions related to SURPASS should be submitted to SURPASS@ARPA-H.GOV. Additional Links:Register for SURPASS EventsSURPASS Program PageSubmit a Teaming Profile

View original listing